Conflict of Interest / Pharma Influence
Following on the heels of an investigative report by David Armstrong of The Wall Street Journal <https://ahrp.org/cms/content/view/286/27/> the Associated Press reports that JAMA claims it was misled.
"Drug companies should not be allowed to evaluate their own products."
Compare and contrast two recent news reports about TeenScreen: Lidia Wasowicz of United Press International provides readers with a sense of the controversy generated by psychiatry’s latest market expansion scheme.
Once again, the New England Journal of Medicine (July 13, 2006) has had to eat crow after it published false and misleading clinical trial findings.
Medical journals are supposed to be vehicles for scientific give and take–not so, evidently, in journals of the American Psychiatric Association.
It is difficult to believe this latest announcement laying claim to a new "under treated" psychiatric disorder–Intermittent Explosive Disorder (IED) is not a parody !!
“There is a crisis of credibility in medicine and science,” says Dr Joseph Sonnabend who, as a former virologist for the Medical Research Council and a retired Aids physician, has watched the basis for public confidence decline.
A.M. (Abe) Rosenthal, hard-edged legendary execlutive editor of The New York Times, died. He is credited with transforming the paper from its genteel "white glove" approach of reporting the news which avoided offending the establishment.
A documented report by David Armstrong of The Wall Street Journal (below) shatters the last glimmer of illusion about The New England Journal of Medicine as a bastion of scientific and moral integrity.
"Virtually every major scientific and medical journal has been humbled recently by publishing findings that are later discredited." NYT
The APRIL 7, 2006 issue of SCIENCE Magazine contains one of the most important articles that tackles research fraud.
"My antennae are definitely up since the whole thing unfolded," acknowledged Rob Stein, science reporter of The Washington Post.
